Evidence map›Paper›PMID 40662447›Full record

Observational studyAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2026

Benzodiazepine Co-Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose.

Adrienne Hughes, Hannah Spungen, Rachel Culbreth, Kim Aldy, Alex Krotulski, Robert G Hendrickson, Alexandra Amaducci, Bryan Judge, Christopher Meaden, Diane P Calello and 9 more

Abstract readObservational Study
In one paragraph

Observational study in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Adrienne HughesOregon Health and Science University, Portland, Oregon, USA.ORCID 0000-0001-5059-7851
Hannah SpungenUniversity of California, Los Angeles, California, USA.ORCID 0000-0003-3740-8854
Rachel CulbrethAmerican College of Medical Toxicology, Phoenix, Arizona, USA.
Kim AldyAmerican College of Medical Toxicology, Phoenix, Arizona, USA.
Alex KrotulskiCenter for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania, USA.ORCID 0000-0003-1775-1882
Robert G HendricksonOregon Health and Science University, Portland, Oregon, USA.ORCID 0000-0002-5998-3908
Alexandra AmaducciLehigh Valley Health Network/USF Morsani College of Medicine, Allentown, Pennsylvania, USA.
Bryan JudgeCorewell Health, Michigan State University, Grand Rapids, Michigan, USA.
Christopher MeadenRutgers New Jersey Medical School, Newark, New Jersey, USA.
Diane P CalelloRutgers New Jersey Medical School, Newark, New Jersey, USA.
Jennie BuchananDenver Health and Hospital Authority, Denver, Colorado, USA.ORCID 0000-0001-9855-8915
Joseph CarpenterEmory University School of Medicine, Atlanta, Georgia, USA.
Joshua ShulmanUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jeffrey BrentUniversity of Colorado School of Medicine, Aurora, Colorado, USA.
Paul WaxAmerican College of Medical Toxicology, Phoenix, Arizona, USA.
Sharan CamplemanAmerican College of Medical Toxicology, Phoenix, Arizona, USA.
Michael LevineUniversity of California, Los Angeles, California, USA.ORCID 0000-0003-3866-0509
Evan SchwarzUniversity of California, Los Angeles, California, USA.
Alex F ManiniIcahn School of Medicine at Mount Sinai, Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND), NYC Health + Hospitals/Elmhurst, New York, New York, USA.

Funding

Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC) R01DA048009 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Alex Francis Manini · 2020 to 2026
$6.7M
NIDA NIH HHS R01 DA048009NIDA NIH HHS R01DA048009
6 · The paper itself

Abstract

backgroundSimultaneous exposure to both benzodiazepines and opioids can lead to synergistic respiratory depression, complicating overdose management. Our objective was to report on the detection of prescription and novel benzodiazepine co-exposures among patients treated in emergency departments (EDs) with suspected opioid overdoses. We aimed to describe novel benzodiazepine exposures in this population and to compare the clinical severity of co-exposure to benzodiazepines and opioids versus opioids alone.

methodsThis study utilized data from the Toxicology Investigators Consortium (ToxIC) Fentalog Study, an observational study at 10 ED sites (Sept 2020-Dec 2023). Waste serum samples were analyzed using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) for the presence of over 1200 novel psychoactive substances (NPS), drugs, therapeutics, and metabolites. Analyses included demographics, clinical severity, and outcomes among those with prescription benzodiazepines, novel benzodiazepines, or no benzodiazepines.

resultsAmong the patients with opioids present (n = 1427), 29.0% of patients had detectable benzodiazepines. 20.5% of patients had detectable prescription benzodiazepines, and 8.5% of patients had detectable novel benzodiazepines. The most commonly detected prescription benzodiazepine was alprazolam (39.3%); the most common novel benzodiazepine was bromazolam (46.3% of novel benzodiazepines). The median age of those with novel benzodiazepines was 34, which was younger than those without benzodiazepines (40) and those with prescription benzodiazepines (41; p = 0.001). Patients without benzodiazepines received naloxone more frequently (p = 0.02), while novel benzodiazepine co-exposure was associated with higher naloxone nonresponse rates (p = 0.03). Patients with novel benzodiazepines (compared to the opioid-only group) had increased odds of requiring mechanical ventilation (aOR: 2.14; 95% CI: 1.07, 4.05) after adjusting for age, gender, race and ethnicity, and the presence of prescription benzodiazepines and/or fentanyl.

conclusionsNearly a third of patients with confirmed opioid overdose presenting to the ED also had concomitant benzodiazepine exposures. Those with novel benzodiazepines had significantly higher odds of intubation, suggesting greater severity of overdose.

Indexed as

Analgesics, OpioidBenzodiazepinesDrug OverdoseEmergency Service, HospitalOpiate OverdoseAdultFemaleHumansMaleMiddle AgedAnalgesics, OpioidBenzodiazepinesbenzodiazepinesnaloxoneopioidsoverdose

Identifiers

PMID40662447
PMCPMC12970572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.